N/A
Completed N=80
Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System
Source: ClinicalTrials.gov NCT04683835 ↗Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcomePrimary: Correlation Between Cognition Level Changes as Evaluated by Current Clinical Tools (i.e. MMSE) and Brain Activity Features Extracted Using the Neurosteer Technology. — 0.1486 Pearson correlation coefficient
Summary
This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through EEG recordings while listening to an auditory cognitive assessment tool. EEG recordings will be analyzed using proprietary computational analyses.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Correlation Between Cognition Level Changes as Evaluated by Current Clinical Tools (i.e. MMSE) and Brain Activity Features Extracted Using the Neurosteer Technology. |
0.1486 | — |
| SECONDARY Inter-patient Variability Between Two Consecutive Measurement Sessions. |
0.583 | — |
Eligibility Criteria
Inclusion Criteria
- Men and women over the age of 50.
- MMSE ≥ 24.
- Patient is able to collaborate.
- No other cognitive comorbidity.
- No seizure events.
Exclusion Criteria
- MMSE < 24.
- Any verbal or non-verbal form of objection from patient or form patient's family member or significant other.
- Presence of several cognitive comorbidity.
- Damage to integrity of scalp and/or skull.
- Skin irritation in the facial and forehead area.
- Significant hearing impairments.
- History of drug abuse.
Data sourced from ClinicalTrials.gov (NCT04683835). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.